178 related articles for article (PubMed ID: 19003993)
21. Expression and characterization of the recombinant aspartic proteinase A1 from Arabidopsis thaliana.
Mazorra-Manzano MA; Yada RY
Phytochemistry; 2008 Oct; 69(13):2439-48. PubMed ID: 18796341
[TBL] [Abstract][Full Text] [Related]
22. Crystal structure of aspartic proteinase from Irpex lacteus in complex with inhibitor pepstatin.
Fujimoto Z; Fujii Y; Kaneko S; Kobayashi H; Mizuno H
J Mol Biol; 2004 Aug; 341(5):1227-35. PubMed ID: 15321718
[TBL] [Abstract][Full Text] [Related]
23. Structural characterization and reversal of the natural organophosphate resistance of a D-type esterase, Saccharomyces cerevisiae S-formylglutathione hydrolase.
Legler PM; Kumaran D; Swaminathan S; Studier FW; Millard CB
Biochemistry; 2008 Sep; 47(36):9592-601. PubMed ID: 18707125
[TBL] [Abstract][Full Text] [Related]
24. Multidisciplinary cycles for protein engineering: site-directed mutagenesis and X-ray structural studies of aspartic proteinases.
Pitts JE; Dhanaraj V; Dealwis CG; Mantafounis D; Nugent P; Orprayoon P; Cooper JB; Newman M; Blundell TL
Scand J Clin Lab Invest Suppl; 1992; 210():39-50. PubMed ID: 1455178
[TBL] [Abstract][Full Text] [Related]
25. Replacement of isobutyl by trifluoromethyl in pepstatin A selectively affects inhibition of aspartic proteinases.
Binkert C; Frigerio M; Jones A; Meyer S; Pesenti C; Prade L; Viani F; Zanda M
Chembiochem; 2006 Jan; 7(1):181-6. PubMed ID: 16307463
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the interaction between the aspartic peptidase inhibitor SQAPI and aspartic peptidases using surface plasmon resonance.
Farley PC; Christeller JT; Sullivan ME; Sullivan PA; Laing WA
J Mol Recognit; 2002; 15(3):135-44. PubMed ID: 12203839
[TBL] [Abstract][Full Text] [Related]
27. Construction, expression and characterization of a chimaeric mammalian-plant aspartic proteinase.
Payie KG; Tanaka T; Gal S; Yada RY
Biochem J; 2003 Jun; 372(Pt 3):671-8. PubMed ID: 12630913
[TBL] [Abstract][Full Text] [Related]
28. BYC, an atypical aspartic endopeptidase from Rhipicephalus (Boophilus) microplus eggs.
Nascimento-Silva MC; Leal AT; Daffre S; Juliano L; da Silva Vaz I; Paiva-Silva Gde O; Oliveira PL; Sorgine MH
Comp Biochem Physiol B Biochem Mol Biol; 2008 Apr; 149(4):599-607. PubMed ID: 18242110
[TBL] [Abstract][Full Text] [Related]
29. Engineering of the yeast antioxidant enzyme Mpr1 for enhanced activity and stability.
Iinoya K; Kotani T; Sasano Y; Takagi H
Biotechnol Bioeng; 2009 Jun; 103(2):341-52. PubMed ID: 19170243
[TBL] [Abstract][Full Text] [Related]
30. Despite having a common P1 Leu, eglin C inhibits alpha-lytic proteinase a million-fold more strongly than does turkey ovomucoid third domain.
Qasim MA; Van Etten RL; Yeh T; Saunders C; Ganz PJ; Qasim S; Wang L; Laskowski M
Biochemistry; 2006 Sep; 45(38):11342-8. PubMed ID: 16981694
[TBL] [Abstract][Full Text] [Related]
31. Probing the role of the conserved beta-II turn Pro-76/Gly-77 of mitochondrial cytochrome c.
Black KM; Wallace CJ
Biochem Cell Biol; 2007 Jun; 85(3):366-74. PubMed ID: 17612631
[TBL] [Abstract][Full Text] [Related]
32. Thermodynamics and specificity of the Mbp1-DNA interaction.
Deleeuw L; Tchernatynskaia AV; Lane AN
Biochemistry; 2008 Jun; 47(24):6378-85. PubMed ID: 18491920
[TBL] [Abstract][Full Text] [Related]
33. Inhibitor binding to the plasmepsin IV aspartic protease from Plasmodium falciparum.
Gutiérrez-de-Terán H; Nervall M; Ersmark K; Liu P; Janka LK; Dunn B; Hallberg A; Aqvist J
Biochemistry; 2006 Sep; 45(35):10529-41. PubMed ID: 16939205
[TBL] [Abstract][Full Text] [Related]
34. Design of peptidomimetic inhibitors of aspartic protease of HIV-1 containing -Phe Psi Pro- core and displaying favourable ADME-related properties.
Frecer V; Berti F; Benedetti F; Miertus S
J Mol Graph Model; 2008 Oct; 27(3):376-87. PubMed ID: 18678515
[TBL] [Abstract][Full Text] [Related]
35. Computational alanine scanning and free energy decomposition for E. coli type I signal peptidase with lipopeptide inhibitor complex.
Li T; Froeyen M; Herdewijn P
J Mol Graph Model; 2008 Jan; 26(5):813-23. PubMed ID: 17532654
[TBL] [Abstract][Full Text] [Related]
36. Structural modeling identified the tRNA-binding domain of Utp8p, an essential nucleolar component of the nuclear tRNA export machinery of Saccharomyces cerevisiae.
McGuire AT; Keates RA; Cook S; Mangroo D
Biochem Cell Biol; 2009 Apr; 87(2):431-43. PubMed ID: 19370060
[TBL] [Abstract][Full Text] [Related]
37. Predicting proteinase specificities from free energy calculations.
Mekonnen SM; Olufsen M; Smalås AO; Brandsdal BO
J Mol Graph Model; 2006 Oct; 25(2):176-85. PubMed ID: 16386933
[TBL] [Abstract][Full Text] [Related]
38. Identification and analysis of functionally important amino acids in human purinergic 12 receptor using a Saccharomyces cerevisiae expression system.
Ignatovica V; Megnis K; Lapins M; Schiöth HB; Klovins J
FEBS J; 2012 Jan; 279(1):180-91. PubMed ID: 22044483
[TBL] [Abstract][Full Text] [Related]
39. Glutamic acid in the inhibitory site of mitochondrial ATPase inhibitor, IF(1), participates in pH sensing in both mammals and yeast.
Ando C; Ichikawa N
J Biochem; 2008 Oct; 144(4):547-53. PubMed ID: 18687699
[TBL] [Abstract][Full Text] [Related]
40. Characterization of a temperature-sensitive mutation that impairs the function of yeast tRNA nucleotidyltransferase.
Shan X; Russell TA; Paul SM; Kushner DB; Joyce PB
Yeast; 2008 Mar; 25(3):219-33. PubMed ID: 18302315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
